tiprankstipranks
Trending News
More News >
NewAmsterdam Pharma Company (NAMS)
NASDAQ:NAMS
US Market
Advertisement

NewAmsterdam Pharma Company (NAMS) Financial Statements

Compare
233 Followers

NewAmsterdam Pharma Company Financial Overview

NewAmsterdam Pharma Company's market cap is currently $3.70B. The company's EPS TTM is $-0.15; its P/E ratio is ―; NewAmsterdam Pharma Company is scheduled to report earnings on August 6, 2025, and the estimated EPS forecast is $-0.41. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Currency in USD

NewAmsterdam Pharma Company Earnings and Revenue History

NewAmsterdam Pharma Company Debt to Assets

NewAmsterdam Pharma Company Cash Flow

NewAmsterdam Pharma Company Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis